Abstract
Uptake of L-[1-14C]ascorbic acid (Asc) of 12.5-200 µM for 1 h intobovine aortic endothelial BAE-2 cells grown to confluence was as low as43-64% (per cell) of uptake into the cells grown to nearly one-fourthconfluence. [14C]Asc undergoing transmembrane uptake was concentrated andaccumulated in the cell less efficiently ([Asc]in/ex = 8-13) at confluencethan at subconfluence ([Asc]in/ex = 15-24). The declined Asc uptake atconfluence is attributable to slowdown of the cell cycle, because a similardecrease in [Asc]in/ex was shown by subconfluent cells precultured inserum-insufficient medium, resulting in an increase in G1 phase andconcurrent decreases in S and G2 + M phase distributions as determined byflow cytometry. [1-14C]Dehydroascorbic acid (DehAsc) was taken up andaccumulated as Asc, after metabolic reduction, without detectable DehAsc.The [Asc]in/ex values for DehAsc at confluence were as low as 15-69%of those at subconfluence in contrast to the values as retentive as62-75% for Asc, suggesting the moderate control of Asc uptake againstslowdown of the cell cycle. At either confluence or subconfluence,dose-dependence for DehAsc uptake was more marked than for Asc uptake asshown by an uphill slope in a curve of doses versus [Asc]in/ex for DehAsc incontrast to a downhill slope for Asc, suggesting the moderate control forAsc uptake against fluctuation of the dose. Increasing of coexistent glucoseof 5 mM to 20-40 mM, plasma concentrations in diabetic patients, declinedDehAsc uptake to 46-48%, which was less moderately controlled thanAsc uptake retained to 59-73%. Asc uptake did not compete with DehAscuptake, suggesting different transporter proteins for Asc and DehAsc. Thus,Asc uptake into the aortic endothelial cells is more moderately controlledagainst slowdown of the cell cycle, decreasing of the extracellularconcentrations or increasing of coexistent glucose than DehAsc uptake,suggesting a homeostatic advantage of Asc over DehAsc in terms of retentionof intracellular Asc contents within a definite range.
Similar content being viewed by others
References
Varani J, Phan SH, Gibbs DF, Ryan US, Ward PA: H2O2-mediated cytotoxicity in rat pulmonary endothelial cells: Changes in purine products and effects of protective intervention. Lab Invest 63: 638–689, 1990
Mayumi T, Schiller HJ, Miyachi M, Bulkley GB: Clinical application of free radical ablation for the prevention of reperfusion injury. In: K Yagi (ed). Active Oxygens, Lipids and Antioxidants. CRC Press, 1993, pp 173–187
Halliwell B, Gutteridge JMC: The antioxidants of extracellular fluids. Arch Biochem Biophys 280: 1–8, 1990
Frei B, Stocker R, Ames BN: Antioxidant defences and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85: 9748–9752, 1988
Jonas E, Dwenger A, Hager A: In vitroeffects of ascorbate on neutrophil-endothelial cell interactions. J Biolumin Chemilumin 8: 15–20, 1993
Dhariwal KR, Hartzell WO, Levine M: Ascorbic acid and dehydroascorbic acid measurements in human plasma. Am J Clin Nutrit 54: 712–716, 1991
Lam KW, Yu HS, Glickman Rd, Lin T: Sodium-dependent ascorbic and dehydroascorbic acid uptake in SV40 transformed retinal pigment epithelial cells. Ophthamol Res 25: 100–107, 1993
Washko P, Levine M: Inhibition of ascorbic acid transport in human neutrophils by glucose. J Biol Chem 269: 23568–23574, 1992
Alexandra EK, Strom K, Cotgreave IA: The uptake of ascorbic acid into human umbilical vein cells and its effect on oxidant insult. Biochem Pharmacol 50: 1339–1346, 1995
Vera JC, Rivas CI, Fischbarg J, Golde DW: Mammalian facilitated hexose transporters mediate the transport of dehydroascorbate. Nature 364: 79–82, 1993
Cornu MC, Moore GA, Nakagawa Y, Moldeus P: Ascorbic acid uptake by isolated rat hepatocytes. Biochem Pharmacol 46: 1333–1338, 1993
Bode AM, Vanderpool SS, Carlson EC, Meyer DA, Rose RC: Ascorbic acid uptake and metabolism by the corneal epithelium. Invest Ophthamol Vis Sci 32: 2266–2271, 1991
Candia OA, Shi X-P, Chu T-C: Ascorbate-stimulated active Na+ transport in rabbit ciliary epithelium. Curr Eye Res 10: 197–203, 1991
DiMattio J, Streitman J: Active transport of ascorbic acid across the retinal pigment epithelium of the bullfrog. Curr Eye Res 10: 959–965, 1991
Dixon SJ, Wilson JX: Adaptive regulation of ascorbate transport in osteoblastic cells. J Bone Mineral Res 7: 675–681, 1992
Welch RW, Bergsten P, Butler JD, Levine M: Ascorbic acid accumulation and transport in human fibroblasts. Biochem J 294: 505–510, 1994
Vera JC, Rivas CI, Zhang RH, Farber CM, Golde DW: Human HL-60 myeloid leukemia cells transport dehydroascorbic acid via the glucose transporters and accumulate reduced ascorbic acid. Blood 84: 1628–1634, 1994
Anderson R, Stankova L, Bigley RH, Bagby GC Jr: Dehydroascorbate uptake as an in vitro biochemical marker of granulocyte differentiation. Canc Res 43: 4696–4698, 1983
Bianichi J, Rose RC: Glucose-independent transport of dehydroascorbic acid in human erythrocytes. Proc Soc Exptl Biol Med 181: 333–337, 1986
Miwa N, Yamazaki H, Ikari Y: Enhancement of ascorbate cytotoxicity by chelation with ferrous ions through prolonged duration of the action. Anticancer Res 6: 1033–1036, 1986
Kageyama K, Onoyama Y, Otani S, Yuasa I, Nagao N, Miwa N: Enhanced inhibitory effects of hyperthermia combined with ascorbic acid on DNA synthesis in Ehrlich tumor cells grown at a low cell density. Cancer Biochem Biophys 14: 273–3 80, 1995
Murakami K, Muto N, Fukuzawa K, Yamamoto I: Comparison of ascorbic acid and ascorbic acid 2-O-alpha-glucoside on the cytotoxicity and bioavailability to low density cultures of fibroblasts. Biochem Pharmacol 44: 2191–2197, 1992
Miwa N, Yamazaki H, Nagaoka Y, Kageyama K, Onoyama Y, Yuasa I, Otani S, Morisawa S: Altered production of the active oxygen species is involved in enhanced cytotoxic action of acylated ascorbate to tumor cells. Biochim Biophys Acta 972: 144–151, 1988
Matsui-Yuasa I, Otani S, Kageyama K, Onoyama Y, Yamazaki H, Miwa N: Effects of acylated derivatived of ascorbate on ornitine decarboxylase induction in Ehrlich ascites tumor cells. Biochem Int 18: 623–629, 1989
Kageyama K, Yamashita T, Kobayashi T, Kimura E: A new rapid and precise method for measuring the intracellular water content by gas chromatography and 3H-sucrose. Experimenta 37: 748–750, 1981
Kremser K, Kremser-Jezik M, Singh I: Effects of hypoxia-reoxygenation on peroxisomal functions in cultured human skin fibroblasts from control and Zellweger syndrome patients. Free Rad Res 22: 39–46, 1995
Chance B, Sies H, Boveris A: Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527–605, 1979
Martensson J, Meister A: GSH deficiency decreases tissue ascorbate levels in newborn rats: Ascorbate spares and protects. Proc Natl Acad Sci USA 88: 4656–4660, 1991
Retsky KL, Freeman MW, Frei B: Ascorbic acid oxidation product(s) protect human low density lipoproteins against atherogenic modification. Anti-rather than prooxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem 268: 1304–1309, 1993
Devamanoharan PS, Morris SM, Varma SD: Oxyradical scavenging effects of dehydroascorbate. Mol Cell Biochem 156: 131–134, 1996
Kanatate T, Nagao N, Sugimoto M, Kageyama K, Fujimoto t, Miwa N: Differential susceptibility of epidermal keratinocytes and neuroblastoma cells to cytotoxicity of ultraviolet-B light irradiation prevented by the oxygen radical-scavenger ascorbate-2-phosphate but not by ascorbate. Cell Mol Biol Res 41: 561–567, 1995
Felton SP, Halver JE: Separation of three commertial forms of vitamin C by HPLC. Proc Soc Exp Biol Med 190: 217–218, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saitoh, Y., Nagao, N., O'Uchida, R. et al. Moderately controlled transport of ascorbate into aortic endothelial cells against slowdown of the cell cycle, decreasing of the concentration or increasing of coexistent glucose as compared with dehydroascorbate. Mol Cell Biochem 173, 43–50 (1997). https://doi.org/10.1023/A:1006879001316
Issue Date:
DOI: https://doi.org/10.1023/A:1006879001316